Tag: frontotemporal lobar dementia
Yumanity secures $500m worth deal with Merck to develop therapies for neurodegenerative disorders
Massachusetts-based Yumanity Therapeutics has secured a drug development deal worth up to nearly $500 million with pharma giant Merck to develop new therapies for neurodegenerative ... Read More